QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
NASDAQ:ATRI

Atrion - ATRI Stock Forecast, Price & News

$631.80
+33.29 (+5.56%)
(As of 12/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$596.10
▼
$631.80
50-Day Range
$565.00
▼
$688.50
52-Week Range
$542.10
▼
$788.00
Volume
5,420 shs
Average Volume
4,405 shs
Market Capitalization
$1.12 billion
P/E Ratio
32.65
Dividend Yield
1.44%
Price Target
N/A

Atrion MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
3.61% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.00mentions of Atrion in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$675,000 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Medical Sector

331st out of 1,022 stocks

Surgical & Medical Instruments Industry

41st out of 101 stocks

See Top Rated MarketRank™ Stocks Here
ATRI stock logo

About Atrion (NASDAQ:ATRI) Stock

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Receive ATRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.

ATRI Stock News Headlines

December 8, 2022 | seekingalpha.com
Atrion: Fair And Reasonably Priced For Resiliency Premium
December 4, 2022 | americanbankingnews.com
Atrion (NASDAQ:ATRI) and Meihua International Medical Technologies (NASDAQ:MHUA) Head to Head Contrast
December 8, 2022 | RJO Futures (Ad)
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile. Take your trading to the next level with the Options Strategy Guide. pixel
November 30, 2022 | finance.yahoo.com
Returns On Capital Signal Tricky Times Ahead For Atrion (NASDAQ:ATRI)
November 28, 2022 | americanbankingnews.com
Atrion Co. (ATRI) to Issue Quarterly Dividend of $2.15 on December 15th
November 10, 2022 | finance.yahoo.com
Atrion Third Quarter 2022 Earnings: EPS: US$4.95 (vs US$4.59 in 3Q 2021)
November 8, 2022 | finance.yahoo.com
Atrion Reports Third Quarter 2022 Results
October 19, 2022 | finance.yahoo.com
Declining Stock and Decent Financials: Is The Market Wrong About Atrion Corporation (NASDAQ:ATRI)?
December 8, 2022 | RJO Futures (Ad)
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile. Take your trading to the next level with the Options Strategy Guide. pixel
October 3, 2022 | finance.yahoo.com
Plurilock's Aurora Systems Receives US$2.8 Million 3-year Purchase Order from a U.S. Food, Facilities, and Uniform Services Provider
September 27, 2022 | proactiveinvestors.com
Plurilock Security earns repeat ‘Buy’ rating from broker Leede Jones Gable after closing of Atrion Communications asset acquisition
September 26, 2022 | finance.yahoo.com
Plurilock's Aurora Announces Closing of Asset Purchase Agreement with Atrion Communications, Inc.
September 15, 2022 | finance.yahoo.com
Atrion (NASDAQ:ATRI) investors are sitting on a loss of 21% if they invested three years ago
September 14, 2022 | nasdaq.com
Ex-Dividend Reminder: NorthWestern, Atrion and Merck
September 8, 2022 | seekingalpha.com
Atrion: Attractively Priced For Exposure To Defensive Healthcare
August 27, 2022 | marketwatch.com
Atrion Taps Cindy Ferguson to Serve as CFO Following Jeffery Strickland's Retirement
August 26, 2022 | finance.yahoo.com
Atrion's (NASDAQ:ATRI) Dividend Will Be Increased To $2.15
August 25, 2022 | finance.yahoo.com
Atrion Corporation Announces CFO Succession Plan
August 22, 2022 | marketwatch.com
Atrion Corp. Raises Dividend by 10%
August 22, 2022 | finance.yahoo.com
Atrion Corporation Increases Quarterly Cash Dividend by 10%
August 9, 2022 | reuters.com
ATRI.O - Atrion Corporation | Stock Price & Latest News | Reuters
August 9, 2022 | proactiveinvestors.com
Plurilock Security announces asset purchase agreement with Atrion Communications
August 9, 2022 | proactiveinvestors.com
Plurilock Security to acquire certain assets of cybersecurity solutions provider Atrion
August 9, 2022 | finance.yahoo.com
Plurilock's Aurora Systems Announces Signing of an Asset Purchase Agreement with Atrion Communications, Inc.
August 8, 2022 | finance.yahoo.com
Atrion Reports Second Quarter 2022 Results
June 22, 2022 | finance.yahoo.com
Returns On Capital At Atrion (NASDAQ:ATRI) Paint A Concerning Picture
May 9, 2022 | finance.yahoo.com
Atrion Reports First Quarter 2022 Results
See More Headlines
Receive ATRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.

ATRI Company Calendar

Last Earnings
11/01/2019
Ex-Dividend for 9/30 Dividend
9/14/2022
Dividend Payable
9/30/2022
Ex-Dividend for 12/15 Dividend
11/30/2022
Today
12/08/2022
Dividend Payable
12/15/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/24/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ATRI
CUSIP
04990410
CIK
701288
Web
www.atrioncorp.com
Phone
(972) 390-9800
Fax
972-396-7581
Employees
667
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
$19.35
Trailing P/E Ratio
32.65
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$33.06 million
Net Margins
19.24%
Pretax Margin
22.36%
Return on Equity
14.16%
Return on Assets
12.82%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.42
Quick Ratio
4.09

Sales & Book Value

Annual Sales
$165.01 million
Price / Sales
6.79
Cash Flow
$26.77 per share
Price / Cash Flow
23.60
Book Value
$135.67 per share
Price / Book
4.66

Miscellaneous

Outstanding Shares
1,773,000
Free Float
1,371,000
Market Cap
$1.12 billion
Optionable
Not Optionable
Beta
0.28

Key Executives

  • Mr. Emile A. Battat (Age 84)
    Exec. Chairman
    Comp: $666.55k
  • Mr. David A. Battat (Age 52)
    Pres & CEO
    Comp: $1.94M
  • Mr. Jeffery Strickland (Age 63)
    CFO, VP, Treasurer & Sec.
    Comp: $986.38k
  • Ms. Cindy Ferguson
    Controller

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













ATRI Stock - Frequently Asked Questions

How have ATRI shares performed in 2022?

Atrion's stock was trading at $704.90 at the start of the year. Since then, ATRI shares have decreased by 10.4% and is now trading at $631.80.
View the best growth stocks for 2022 here.

When is Atrion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 24th 2023.
View our ATRI earnings forecast.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) issued its quarterly earnings data on Friday, November, 1st. The medical instruments supplier reported $5.15 EPS for the quarter. The medical instruments supplier earned $38.88 million during the quarter. Atrion had a trailing twelve-month return on equity of 14.16% and a net margin of 19.24%.

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion declared a quarterly dividend on Monday, November 14th. Stockholders of record on Thursday, December 1st will be paid a dividend of $2.15 per share on Thursday, December 15th. This represents a $8.60 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date is Wednesday, November 30th.
Read our dividend analysis for ATRI.

Is Atrion a good dividend stock?

Atrion (NASDAQ:ATRI) pays an annual dividend of $8.60 per share and currently has a dividend yield of 1.44%. The company has been increasing its dividend for 18 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 44.44%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for ATRI.

What is David A. Batta's approval rating as Atrion's CEO?

1 employees have rated Atrion Chief Executive Officer David A. Batta on Glassdoor.com. David A. Batta has an approval rating of 100% among the company's employees. This puts David A. Batta in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Atrion to a friend.

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP), AT&T (T), WestRock (WRK), AbbVie (ABBV), Caterpillar (CAT), Eastman Chemical (EMN), Gilead Sciences (GILD), Altria Group (MO), Pfizer (PFE) and Philip Morris International (PM).

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

Who are Atrion's major shareholders?

Atrion's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Neuberger Berman Group LLC (11.11%), Kayne Anderson Rudnick Investment Management LLC (10.59%), BlackRock Inc. (6.25%), Vanguard Group Inc. (4.70%), Dimensional Fund Advisors LP (2.91%) and Renaissance Technologies LLC (2.29%). Insiders that own company stock include Emile A Battat and Jeffery Strickland.
View institutional ownership trends.

How do I buy shares of Atrion?

Shares of ATRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $631.80.

How much money does Atrion make?

Atrion (NASDAQ:ATRI) has a market capitalization of $1.12 billion and generates $165.01 million in revenue each year. The medical instruments supplier earns $33.06 million in net income (profit) each year or $19.35 on an earnings per share basis.

How many employees does Atrion have?

The company employs 667 workers across the globe.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The official website for the company is www.atrioncorp.com. The medical instruments supplier can be reached via phone at (972) 390-9800, via email at ir-info@atrioncorp.com, or via fax at 972-396-7581.

This page (NASDAQ:ATRI) was last updated on 12/8/2022 by MarketBeat.com Staff